CD72 | CD72 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD80 | CD80 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD84 | CD84 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD8A | CD8a molecule | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD8B | CD8b molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDCA4 | Cell division cycle associated 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CDT1 | Chromatin licensing and DNA replication factor 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
CENPU | Centromere protein U | Predicted intracellular proteins
| | | | | Tissue enhanced |
CKAP2L | Cytoskeleton associated protein 2-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
CLC | Charcot-Leyden crystal galectin | Predicted intracellular proteins
| | | | | Tissue enriched |
CLEC12A | C-type lectin domain family 12, member A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CTSW | Cathepsin W | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL8 | Chemokine (C-X-C motif) ligand 8 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA1B | Defensin, alpha 1B | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA3 | Defensin, alpha 3, neutrophil-specific | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
DEFA4 | Defensin, alpha 4, corticostatin | Predicted secreted proteins
| | | | | Tissue enriched |
DENND1C | DENN/MADD domain containing 1C | Predicted intracellular proteins
| | | | | Tissue enhanced |
DPPA4 | Developmental pluripotency associated 4 | Predicted intracellular proteins
| | | | | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
EAF2 | ELL associated factor 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
EBLN2 | Endogenous Bornavirus-like nucleoprotein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
EN1 | Engrailed homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
EPB42 | Erythrocyte membrane protein band 4.2 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FAM110B | Family with sequence similarity 110, member B | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM111B | Family with sequence similarity 111, member B | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM9C | Family with sequence similarity 9, member C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
FBXO5 | F-box protein 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FCAR | Fc fragment of IgA, receptor for | CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |